Medtronic(US:MDT) Zhi Tong Cai Jing·2025-11-18 14:08Core Insights - Medtronic (MDT.US) shares rose 4% in pre-market trading, reaching $100.14 [1] - For Q2 of fiscal year 2026, Medtronic reported a non-GAAP EPS of $1.36, up from $1.26 a year ago, exceeding analyst expectations of $1.31 [1] - The quarterly net sales for the period ending October 24 were $8.96 billion, compared to $8.4 billion in the same quarter last year, surpassing the expected $8.87 billion [1] - Medtronic raised its fiscal year 2026 non-GAAP EPS guidance to a range of $5.62 to $5.66, up from the previous guidance of $5.60 to $5.66, aligning with analyst expectations of $5.62 [1] - The new earnings guidance includes an estimated impact of approximately $185 million from potential tariffs [1] - The revenue growth forecast for fiscal year 2026 was increased from 5% to 5.5% [1]